io102-103
Showing 1 - 1 of 1
Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- IO102-103
-
Baltimore, MarylandJohns Hopkins University
Aug 2, 2023